Your Article Summary
See Latest ArticlesGraves Hyperthyroidism after Stopping Immune Suppressive Therapy in Type 1 Diabetic Islet Cell Recipients with Pretransplant TPO-Autoantibodies
Diabetes Care, 07/02/09
Keymeulen B et al. - Type 1 diabetic recipients of islet cell grafts with pretransplant TPO-autoantibody positivity exhibit a high risk for developing Graves' hyperthyroidism after immune suppressive therapy is discontinued for a failing graft.
Related Articles
Activating Autoantibodies to the Beta-1 Adrenergic and M2 Muscarinic Receptors Facilitate Atrial Fibrillation in Patients With Graves' Hyperthyroidism
JACC - Journal of the American College of Cardiology, 10/05/09
Relevance Score: 68%
Graves' Disease Associated with Primary Systemic Sclerosis
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09
Relevance Score: 65%
Recurrence of Graves' Disease in Thyroglossal Duct Remnants: Relapse After Total Thyroidectomy
Thyroid, 11/19/09
Relevance Score: 44%
Herpes virus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease
European Journal of Endocrinology, 11/19/09
Relevance Score: 43%
Premature hair greying may predict reduced bone mineral density in Graves' disease
Irish Journal of Medical Science, 10/27/09
Relevance Score: 43%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Individuation of different metabolic phenotypes in normal glucose tolerance test
Acta Diabetologia, 11/25/09
Are Hemoglobin Levels Elevated in Type 1 Diabetes
Diabetes Care, 11/25/09
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09